Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/11/e001391corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!